97 related articles for article (PubMed ID: 1478125)
1. [Effect of captopril on the exercise performance in patients with congestive heart failure].
Han YL; Tong M; Miao ZL
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):281-3, 317. PubMed ID: 1478125
[TBL] [Abstract][Full Text] [Related]
2. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
Northridge DB; Currie PF; Newby DE; McMurray JJ; Ford M; Boon NA; Dargie HJ
Eur J Heart Fail; 1999 Mar; 1(1):67-72. PubMed ID: 10937982
[TBL] [Abstract][Full Text] [Related]
4. Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial.
Borgi C; Magelli C; Costa FV; Magnani B; Ambrosioni E
Clin Cardiol; 1990 May; 13(5):329-34. PubMed ID: 2189613
[TBL] [Abstract][Full Text] [Related]
5. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
6. [Renal effects of captopril in chronic heart failure].
Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of intravenous captopril in heart failure].
Wu H; Zhao HY
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):161-4. PubMed ID: 8222978
[TBL] [Abstract][Full Text] [Related]
8. [Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation].
Ferreira Filho SR; Hatab SA; Benchimol C; Nascimento LO; Saragoça MA
Arq Bras Cardiol; 1992 Dec; 59(6):487-91. PubMed ID: 1341875
[TBL] [Abstract][Full Text] [Related]
9. [Acute and long-term effects of captopril in patients with left ventricular dysfunction and dilatation: evaluation of function and work capacity].
Foresti A; Bertoni T; Gentile G; Kheir A; Nardi B; Lotto A
G Ital Cardiol; 1989 Nov; 19(11):999-1006. PubMed ID: 2695386
[TBL] [Abstract][Full Text] [Related]
10. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
[TBL] [Abstract][Full Text] [Related]
11. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG
Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failure.
Gronda E; Brusoni B; Mangiavacchi M; Oppizzi M; Inglese E; Caroli A; Rovelli F
Postgrad Med J; 1986; 62 Suppl 1():167-9. PubMed ID: 3534856
[TBL] [Abstract][Full Text] [Related]
13. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
Arcensio SR; Barretto AC; Szambock F; Mady C; Arteaga E; da Luz PL; Bellotti G; Pileggi F
Arq Bras Cardiol; 1994 Nov; 63(5):409-13. PubMed ID: 7611921
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic and clinical effects of captopril in congestive heart failure].
Galiè N; Magelli C; Ribani MA; Bassein L; Sanguinetti M; Magnani B
G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
[TBL] [Abstract][Full Text] [Related]
16. The antiarrhythmic effect of the ACE inhibitor captopril in patients with congestive heart failure largely is due to its potassium sparing effects.
Poquet F; Ferguson J; Rouleau JL
Can J Cardiol; 1992; 8(6):589-95. PubMed ID: 1504913
[TBL] [Abstract][Full Text] [Related]
17. Converting-enzyme inhibitor therapy for chronic heart failure.
Massie BM; Kramer BL; Topic N
Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
[TBL] [Abstract][Full Text] [Related]
18. [Right ventricular function and effort tolerance in patients with chronic congestive heart insufficiency. A cross-over double-blind study].
Montes Orbe PM; Ormaetxe JM; Martínez JD; Rodríguez E; Ruiz de Azúa E; Iriarte MM
Rev Esp Cardiol; 1990 Mar; 43(3):137-41. PubMed ID: 2185526
[TBL] [Abstract][Full Text] [Related]
19. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
Escobar E; Ojeda G; Saavedra M; Thumala A
Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
[No Abstract] [Full Text] [Related]
20. [Acute and long-term effect of captopril in severe chronic heart failure].
Kikis D; Heck I; Stumpe KO; Esser H
Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]